Ampio Pharmaceuticals Inc.
AMPE
AMPE was delisted on the 12th of April, 2024.
103 hedge funds and large institutions have $40M invested in Ampio Pharmaceuticals Inc. in 2020 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 30 increasing their positions, 12 reducing their positions, and 7 closing their positions.
314% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 7
150% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 12
129% more capital invested
Capital invested by funds: $17.5M → $40M (+$22.5M)
27% more funds holding
Funds holding: 81 → 103 (+22)
19% more call options, than puts
Call options by funds: $1.94M | Put options by funds: $1.63M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$1.66M |
| 2 |
WIC
Willis Investment Counsel
Gainesville,
Georgia
|
+$1.33M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.18M |
| 4 |
PCMC
Private Capital Management (Colorado)
Denver,
Colorado
|
+$1.02M |
| 5 |
California Public Employees Retirement System
Sacramento,
California
|
+$377K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
-$109K |
| 2 |
WS
Wedbush Securities
Los Angeles,
California
|
-$63K |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$54.5K |
| 4 |
GWM
Geneos Wealth Management
Englewood,
Colorado
|
-$37.7K |
| 5 |
HighTower Advisors
Chicago,
Illinois
|
-$35K |
AMPE Hedge Fund Activity: Q4 2020 in Review
103 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q4 2020, worth a combined $40M — up 129% from $17.5M a quarter earlier.
Buyers outnumbered sellers: 29 funds opened new AMPE positions and 7 closed out — a net gain of 22 holders — while 30 added to existing stakes and 12 trimmed.
The largest buyer was BlackRock, adding an estimated $1.66M. The largest seller was Wells Fargo, cutting an estimated $109K.
- 103 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q4 2020, up from 81 in Q3 2020.
- Funds reported $40M of Ampio Pharmaceuticals Inc. stock for Q4 2020, up 129% quarter-over-quarter.
- 29 funds opened new Ampio Pharmaceuticals Inc. positions in Q4 2020 and 7 closed out, a net change of +22 holders.
- The largest Ampio Pharmaceuticals Inc. buyer in Q4 2020 was BlackRock, an estimated $1.66M added.
- The largest Ampio Pharmaceuticals Inc. seller in Q4 2020 was Wells Fargo, an estimated $109K sold.
Based on aggregated 13F filings for Q4 2020.